Sangamo Therapeutics
SGMO
SGMO
110 hedge funds and large institutions have $27.3M invested in Sangamo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 25 closing their positions.
Holders
110
Holders Change
-12
Holders Change %
-9.84%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
30
Reduced
31
Closed
25
Calls
$423K
Puts
$421K
Net Calls
+$2K
Net Calls Change
+$77K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$3.7M |
2 |
GCP
2
GSA Capital Partners
London,
United Kingdom
|
$1.22M |
3 |
WA
3
Wasatch Advisors
Salt Lake City,
Utah
|
$4.38M |
4 |
4
UBS Group
Zurich,
Switzerland
|
$676K |
5 |
5
Squarepoint
New York
|
$338K |